Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 20,000 shares at $10.79 ($216K) on 2017-11-20, disclosed to the SEC on 2017-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.79 | 10,000 | $108K | 50.0% |
| 2 | $10.79 | 10,000 | $108K | 50.0% |
| Total | $10.79 avg | 20,000 | $216K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |